Erratum: Sharper Focus, Greater Comfort? Lessons From the ROBOMET Trial
E
Edward Chmiel
M
Matthias Guckenberger
(Department of Radiation Oncology, University Hospital Zurich, University of Zurich, Zurich, Switzerland)
E
Erin F. Gillespie
S
Shankar Siva
Article Details
Journal
Journal of Clinical Oncology
Volume / Issue
Vol. 43, Issue 24
Published
August 20, 2025
Pages
2757-2757
ISSN
0732-183X
Publisher
Lippincott Williams & Wilkins
Journal Info
Journal of Clinical Oncology
Lippincott Williams & Wilkins
ISSN: 0732-183X Health Sciences
Authors (4)
E
Edward Chmiel
M
Matthias Guckenberger
Department of Radiation Oncology, University Hospital Zurich, University of Zurich, Zurich, Switzerland
E
Erin F. Gillespie
S
Shankar Siva
Related Articles from this Journal
Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer
Ismaela Anna Vascotto, Filippo Antonica et al.
Aug 2026
10.1200/jco-26-00658
Allogeneic CD70-Targeted Chimeric Antigen Receptor T-Cell Therapy for Advanced Renal Cell Carcinoma: Results From the Phase I TRAVERSE Trial
Samer A. Srour, Jad Chahoud et al.
Aug 2026
10.1200/jco-26-00388
Adjuvant Carboplatin for Early-Stage, Triple-Negative Breast Cancer: Taxane and Patient Selection
Risako Komata, Kenju Ando et al.
Aug 2026
10.1200/jco-26-00140
Erratum: All-Oral Combination of Revumenib, Decitabine, and Venetoclax for Relapsed or Refractory AML (SAVE)
Ghayas C. Issa, Branko Cuglievan et al.
Aug 2026
10.1200/jco-26-01743
Reply to: Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer
Irbaz Bin Riaz, R. Bryan Rumble et al.
Aug 2026
10.1200/jco-26-01001